| | 
Part, Chapter, Paragraph
1 I, 2. 10. 4| spent in the dispensary by 34% for pharmacists and 51%
2 II, 4. 3 | Health and Human Services: 34.~ ~Van Oyen, H., J. van
3 II, 5. 2. 3| age-range, CVD accounts for 34% of total mortality and
4 II, 5. 2. 3| 225 to 142 per 100.000), 34% in Southern Europe countries6 (
5 II, 5. 2. 3| 110 to 87 per 100.000), 34% in Central Eastern Europe (
6 II, 5. 2. 7| Arch Intern Med 165:1028-34.~EUROCISS Project Research
7 II, 5. 2. 7| or case fatality?. Stroke 34:1833-1841~Thom TJ (1989):
8 II, 5. 3. 2| 2005, collected data from 34 European countries regarding
9 II, 5. 3. 5| 17 deaths (in Iceland) to 34 deaths per 100,000 (in Denmark).
10 II, 5. 3. 6| Sweden (70%) (Figure 5.3.34) (Sant et al, 2003). Survival
11 II, 5. 3. 6| al, 2003).~ ~Figure 5.3.34. Cervical cancer (ICD9 180)
12 II, 5. 5. 3| show a peak in the 30 – 34 age group and again between
13 II, 5. 5. 3| in Italy, 35% in Denmark, 34% in Hungary, 26% in Germany,
14 II, 5. 5. 3| Wirksamkeit. Psychiat Prax 34(1):S28-S32.~Priebe S (2007):
15 II, 5. 5. 3| studies on epilepsy. Epilepsia 34:592-596.~Employment Committee
16 II, 5. 6. 6| Norway. Scand J Soc Med 26:34-43~Brooks PM (1997): MJA
17 II, 5. 6. 6| ESCISIT). Ann Rheum Dis 66(1):34-45~Cooper C (1997): The
18 II, 5. 6. 6| Chingford Study. Arthritis Rheum 34, S171~ ~Spector TD, Hart
19 II, 5. 8. 3| complications and exacerbations, and 34% to other diseases, one-third
20 II, 5. 8. 7| disease. Intern Med J 2004;34(11):608-14~ ~ ~Schirnhofer
21 II, 5. 9. 4| significantly narrowed for wheeze (1.34 to 0.98:1 P <0.0002), asthma (
22 II, 5. 10. 7| L 75, 22.03.2005, pp. 33–34.~htt ~ ~European Commission (
23 II, 5. 11. 3| Environment, 2007;388:24-34.~L Dotterud, E Falk, Metal
24 II, 5. 11. 3| following age groups:15–24, 25–34, 35–54 and 55–74, respectively (
25 II, 5. 11. 7| J Dermatol 1994;131(S44):34.~ ~Johnson M-LT (1978):
26 II, 5. 12. 3| as well as in Austria (34.5) and Hungary (33.9), while
27 II, 5. 12. 3| whose rates declined from 27-34 in 1980-82 to 18-20/100,
28 II, 5. 12. 7| randomized trial. Endoscopy 34:690-697.~ ~Schuppan D, Afdhal
29 II, 6. 3. 3| were reported by Ireland (34.99), Sweden (28.96), and
30 II, 6. 3. 6| 000 per year). In 2005, 34 cases were reported by 20
31 II, 7. 3. 1| 000 Hospital Admissions~- 34 200 000 Hospital Outpatients~-
32 II, 7. 3. 2| injury fatalities are male, 34% female (Figure 7.3).~ ~
33 II, 8. 2. 1| mental retardation of 0.34% (Bersen, 1976).~ ~Prevalence
34 II, 9 | Smoking Among all Women 25-34 vs Women During 3rd Trimester
35 II, 9. 1. 2| Smoking Among all Women 25-34 vs Women During 3rd Trimester
36 II, 9. 3. 1| 000 population), to the 25-34 age group (11.2 per 100
37 II, 9. 3. 1| of death in men aged 15-34 as deaths due to pulmonary
38 II, 9. 3. 1| rise between the ages of 25-34 and 35-44 in the rate of
39 II, 9. 3. 1| 40-49, 15.7% aged 50-59, 34.4% aged 60-69 and 53.4%
40 II, 9. 3. 2| outcomes after birth at 30-34 weeks of gestation. Obstet
41 II, 9. 3. 3| 1989-2003). Arch Sex Behav 34:219-29.~Hessling A (Ed.) (
42 III, 10. 2. 1| one occasion and a further 34% 5 or more drinks (50g alcohol).
43 III, 10. 2. 1| use in young adults (15-34 y) have been registered
44 III, 10. 2. 1| use among young adults (15-34 year old)~ ~Most drug use
45 III, 10. 2. 1| is taking place among 15-34 year olds and lifetime prevalence
46 III, 10. 2. 1| young adults (aged 15 to 34)~ ~Drug use in the European
47 III, 10. 2. 1| 64) and young adults (15-34). Nowadays, we can observe
48 III, 10. 2. 1| cocaine use among the 15–34 age group have been registered
49 III, 10. 2. 1| Starting with Eurobarometer 34 (1990) separate supplementary
50 III, 10. 2. 1| found that about a third (34%) reported enough physical activity
51 III, 10. 2. 1| survey indicating that up to 34% of 13-year-old boys versus
52 III, 10. 2. 1| showed a range of 7-27% and 34-68%, respectively. The few
53 III, 10. 2. 1| Commission Directive 2006/34/EC (European Commission,
54 III, 10. 2. 1| Commission (2006): Directive 2006/34/EC of 21 March 2006 amending
55 III, 10. 4. 2| Chapter V (articles 26 through 34) considers the following
56 III, 10. 4. 2| regard to Article 23f and 34 of Regulation (EC) 178/2002,
57 III, 10. 4. 2| 2006): Directive No. 2006/34/EC of 21 March 2006 amending
58 III, 10. 4. 3| 60%) of the outbreaks and 34.8% of the cases of illnesses.
59 III, 10. 4. 5| from 27% in 1990 to 33%-34% in 2005, with exports being
60 III, 10. 5. 2| Poland, Slovakia~Rural: 34~Urban: 17~ ~2006-Accession
61 III, 10. 6. 2| countries. Int J Epidemiol 34: 316-326.~ ~EUROTHINE (2007):
62 IV, 11. 2. 1| beds can be seen in Malta (34%), the Netherlands (33%),
63 IV, 12. 5 | parliamentary decision (34/2001/EC, adopted by the
64 IV, 12. 10 | Directives 93/104, 2000/34’’~o Presidential Degrees
|
|
| |
